Nefiracetam vs Pramiracetam for mood
Short answer: For mood, more users report improvement with Nefiracetam — 75% of 8 reports, versus 45% of 22 for Pramiracetam.
Nefiracetam has 1 meta-analyses and 3 randomized trials on PubMed; Pramiracetam has 0 and 3.
Based on 31 reports about Nefiracetam and 343 about Pramiracetam. Not medical advice.
| Nefiracetam Supplement | Pramiracetam Supplement | |
|---|---|---|
| Users say it helped | 73%helped14 reports · few reports | 59%helped127 reports · high confidence |
| Verdict | Mostly positive | Mixed |
| Research | BResearch: Moderate | CResearch: Limited |
| Meta-analyses / RCTs | 1 / 3 | 0 / 3 |
| Mainly used for | ||
| Focus % reporting improvement | 100% (7) | 95% (91) |
| Memory % reporting improvement | 100% (4) | 95% (38) |
| Mood % reporting improvement | 75% (8) | 45% (22) |
| Energy % reporting improvement | — | 91% (11) |
| Anxiety % reporting improvement | — | 100% (8) |
| Common side effects | kidney pain, testicular shrinkage, sneeze, headache | headache, emotional blunting, fatigue, bad taste |
| Typical dose reported | 5 mg/kg / 2x/day | 1 teaspoon |
Several interventions, including escitalopram, donepezil, motor relearning programs, strategy training, and rTMS, have demonstrated potential effectiveness in treating post-stroke apathy. Nevertheless, evidence remains scarce and heterogeneous, underscoring the need for larger, high-quality randomized controlled trials to establish definitive treatment guidelines.
Front Neurol, 2025 ↗“I love this one. Nice little mood brightener. ... it helps me connect the dots at work and when doing everyday activities.”
“I was very anxious and listless for a while and the substances that helped me the most were Pramiracetam + alpha GPC.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate